scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Z Huang | |
S K Samal | |||
A Panda | |||
S Elankumaran | |||
P433 | issue | 6 | |
P921 | main subject | Newcastle disease | Q11903425 |
Newcastle disease virus | Q327082 | ||
vector-borne disease | Q2083837 | ||
P304 | page(s) | 899-906 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | Poultry Science | Q1999242 |
P1476 | title | Recombinant Newcastle disease virus as a vaccine vector. | |
P478 | volume | 82 |
Q35112976 | A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen. |
Q37492711 | A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. |
Q37800864 | Advances in avian immunology—prospects for disease control: a review |
Q28261383 | Avian Paramyxovirus: A Brief Review |
Q30227194 | Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target |
Q92640537 | Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates |
Q42250216 | Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge |
Q99578111 | Current status of virus-vectored vaccines against pathogens that affect poultry |
Q37024583 | Disparate thermostability profiles and HN gene domains of field isolates of Newcastle disease virus from live bird markets and waterfowl in Uganda |
Q30382097 | Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. |
Q92755752 | Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice |
Q44586935 | Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses |
Q41325120 | Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings |
Q40715597 | Generation of Newcastle Disease Virus (NDV) Recombinants Expressing the Infectious Laryngotracheitis Virus (ILTV) Glycoprotein gB or gD as Dual Vaccines. |
Q59356175 | Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector |
Q40293099 | Generation of measles virus with a segmented RNA genome |
Q33490614 | Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses |
Q38851002 | Immunogenicity and protection efficacy evaluation of avian paramyxovirus serotype-1 (APMV-1) isolates in experimentally infected chickens |
Q45357944 | Isolation of Newcastle disease virus from a non-avian host (sheep) and its implications. |
Q42269895 | Modulation by essential oil of vaccine response and production improvement in chicken challenged with velogenic Newcastle disease virus |
Q57169065 | Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis |
Q34057946 | Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges. |
Q40095159 | Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines. |
Q38192846 | Newcastle disease virus: current status and our understanding |
Q27027003 | Novel approaches to develop Rift Valley fever vaccines |
Q47144787 | Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) to review Newcastle disease focussing on vaccination worldwide in order to determine its optimal use for disease control purposes |
Q90062199 | Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens |
Q52717318 | Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge. |
Q38559266 | Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases |
Q30380898 | Recombinant vectors as influenza vaccines. |
Q39186172 | Rescue of recombinant Newcastle disease virus: a short history of how it all started |
Q38970464 | Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems. |
Q40479713 | Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus. |
Q37468199 | The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties |
Q34102268 | Virus-vectored influenza virus vaccines |
Search more.